Trial intelligence / Profile preview

Seizure Prophylaxis in Brain Tumor Surgery

NCT03436433Phase 2Terminated

Sponsor
Duke University
Start
Jan 2019
Primary completion
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lacosamide, levetiracetam in epilepsy, sponsored by Duke University. Started Jan 2019; status: terminated.

02

Drugs

lacosamidelevetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on NCT03436433.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03436433.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call